Raynaud's Syndrome

Raynaud’s phenomenon/syndrome causes the narrowing of the blood vessels located in extremities, which results in a reduction of blood flow to these parts.

Severity

Typically, the syndrome is not life-threatening and most people with mild forms of the disease remain without treatment.

Affected Demographic

Raynaud's syndrome affects as many as 5% of Americans, 80% of which are women.

Treatment

Raynaud’s syndrome isn’t entirely curable but its symptoms are treatable. Dermatologists aim to reduce the severity of the episodes, reduce the number of episodes, and prevent intense tissue damage. Even though there are currently no FDA-approved drugs for this syndrome, dermatologists may prescribe drugs that can treat the symptoms.

Sources

1. UC Davis Health, Vascular Center. “Raynaud’s Disease (Raynaud’s Phenomenon).” Raynaud’s Disease | Vascular Center | UC Davis Health, health.ucdavis.edu/vascular/diseases/raynauds_disease.html#:~:text=As%20many%20as%20five%20percent,with%20the%20condition%20are%20women.
2. “Raynaud’s Phenomenon.” National Institute of Arthritis and Musculoskeletal and Skin Diseases, U.S. Department of Health and Human Services, 6 Sept. 2024, www.niams.nih.gov/health-topics/raynauds-phenomenon/diagnosis-treatment-and-steps-to-take.